Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03869840 · ClinicalTrials.gov registry record
Accuracy of Detection of Methemoglobin With Pulse Oximetry
A clinical trial, sponsored by Nonin Medical.
- Completed
- Registry status
- 13
- Enrollment target
NCT03869840: Completed study, sponsored by Nonin Medical.
NCT03869840 is a clinical trial that has completed, run by Nonin Medical. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03869840 has completed, sponsored by Nonin Medical.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
The non-invasive measurement of dysfunctional hemoglobins allows physicians to monitor levels in affected individuals without requiring blood samples or laboratory testing. Nonin Medical Inc, has recently developed a multi-wavelength device that measures carboxyhemoglobin and methemoglobin non-invasively. The primary objective of this study is to validate %MetHb and SpO2 accuracy performance of the study device. Evaluations will be for the range of 0 to 15% MetHb with 95-100% SaO2 as assessed by CO-oximetry, and 0-15% MetHb accuracy under conditions of elevated HHb (SaO2 80-100%) as assessed by CO-oximetry, and SpO2 with 80-100% SaO2 during elevated MetHb as assessed by CO-oximetry.
Interventions
- DEVICE Sensor to spot check blood levels
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2019-03-26 |
| Est. Completion | 2019-03-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03869840
The ClinicalTrials.gov registry entry for NCT03869840 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nonin Medical, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sensor to spot check blood levels is the first listed.
NCT03869840 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03869840 about?
NCT03869840 is a clinical study titled "Accuracy of Detection of Methemoglobin With Pulse Oximetry". The non-invasive measurement of dysfunctional hemoglobins allows physicians to monitor levels in affected individuals without requiring blood samples or laboratory testing. Nonin Medical Inc, has recently developed a multi-wavelength device that measures carboxyhemoglobin and methemoglobin non-invas...
What is the current status of trial NCT03869840?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2019-03-26. Estimated completion is 2019-03-29.
What interventions are being tested in trial NCT03869840?
The interventions under investigation include: Sensor to spot check blood levels (DEVICE).
Who is sponsoring clinical trial NCT03869840?
This trial is sponsored by Nonin Medical, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.